SCHEMBL1636908

SCHEMBL1636908

CC(C)(C)c1cccc(-c2cccc(C(=O)c3ccccn3)c2)c1OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 10/20 0.45
KMT2A Q03164 1/20 0.43
CYP2C9 P11712 2/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
GRM5 P41594 1/20 0.39
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
CYP3A4 P08684 1/20 0.39
FFAR1 O14842 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
SRD5A2 P31213 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1637994 0.88 PTGER1 (0.40) PTGER1CYP2C9RXRARXRBRXRG
SCHEMBL12646955 0.86 KMT2A (0.40) KMT2ACYP2C9RXRARXRBRXRG
SCHEMBL1637811 0.84 MAOB (0.54) PTGER1CYP2C9RXRARXRBRXRG
SCHEMBL1638990 0.82 FFAR1 (0.47) PTGER1RXRARXRBRXRGNR1H2
SCHEMBL12725979 0.76 ADORA3 (0.50) PTGER1KMT2ARXRARXRBRXRG
SCHEMBL1638313 0.76 LMNA (0.39) PTGER1GRM5LMNAHPGDFFAR1
SCHEMBL1759295 0.75 FEN1 (0.42) PTGER1RXRARXRBRXRGGRM5
SCHEMBL27877465 0.75 PTGER1 (0.43) PTGER1RXRARXRBRXRGFFAR1
SCHEMBL1638838 0.74 MAOA (0.51) PTGER1RXRARXRBRXRGPTGER4
SCHEMBL12646951 0.74 CYP1A2 (0.36) KMT2ACYP2C9RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541522-B2 Catalyst compounds and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-24 US disclosed
US-8541522-B2 Catalyst compounds and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-24 US disclosed
US-20110098429-A1 Catalyst Compounds and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-28 US disclosed
US-20110098429-A1 Catalyst Compounds and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098429-A1 Catalyst Compounds and Use Thereof ALOX12, THEM6, ALOX15 PTGER1 2069/4885KMT2A 3425/4885CYP2C9 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.